OncoResponse
OncoResponse is a biotech company developing antibody-based cancer immunotherapies.
Facts
- HQ
- Seattle, US
- Sectors
- Research
- Founded
- 2016
- Type
- Corporation Seattle business license
- Employees
- 9
- Registered name
- OncoResponse Inc Seattle business license
- Stage
- Series D
- Members see funding amounts. .
Is this your organization? Claim it
OncoResponse raises $150M total, closes $6M Series D in April 2025; backed by ARE, Rice University, Takeda
OncoResponse, headquartered in Seattle, has raised $150M total with a recorded $6M Series D round in April 2025 and is backed by investors including ARE, Rice University, and Takeda Pharmaceuticals.
OncoResponse Raises $27M to Advance Antibody-Based Cancer Immunotherapies OR502 and OR2805
Seattle biotech firm OncoResponse secured $27 million to advance testing of its antibody-based cancer immunotherapy candidates OR502 and OR2805. The funding includes a $13 million grant from the Cancer Prevention and Research Institute of Texas and $14 million from investors led by RiverVest Venture Partners.
Just–Evotec Biologics opens 130,000 sq ft Redmond J.POD to manufacture COVID‑19 antibody therapeutics for U.S. Defense
Just–Evotec Biologics opened a 130,000 sq ft J.POD drug manufacturing facility in Redmond, Washington that uses continuous, autonomous bioprocessing to design, develop and produce antibody therapeutics more efficiently and at lower cost. The plant will manufacture antibodies for the U.S. Department of Defense to potentially treat COVID-19 and supports both small- and large-scale production for biotech customers globally.
People
-
Clifford Stocks Founder, Executive Officer, Director, Chief Executive Officer
Online
Questions about OncoResponse
What is OncoResponse?
oncoresponseinc.com
Who are the people behind OncoResponse?
Seattle Flow lists Clifford Stocks (Founder, Executive Officer, Director, Chief Executive Officer) at OncoResponse.
Who invested in OncoResponse, and how much has it raised?
Members of Seattle Flow see OncoResponse's funding rounds, amounts and investors on its Funding tab. Joining is free.
Where is OncoResponse based?
OncoResponse is headquartered in Seattle, US.
When was OncoResponse founded?
OncoResponse was founded in 2016.
How many people work at OncoResponse?
OncoResponse has 9 employees.